等待开盘 06-30 09:30:00 美东时间
+0.580
+1.22%
今日重点评级关注:Chardan Capital:维持Ocular Therapeutix"买入"评级,目标价从21美元升至23美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从30美元升至40美元
06-26 17:42
U.S. stocks were higher, with the Nasdaq Composite gaining more than 50 points on Wednesday. Shares of KB Home (NYSE:KBH) rose sharply after the company reported financial results for the second quarter. KB Home reported second-quarter revenue of $1.11 billion, beating analyst estimates of $1.10 bil...
06-24 21:56
Horizon Quantum Holdings Ltd Class A涨11.41%;Infleqtion, Inc.涨10.20%;D-Wave Quantum涨6.78%
06-23 10:01
Infleqtion, Inc.涨13.86%;D-Wave Quantum涨8.01%;Rigetti Computing, Inc.涨7.25%
06-23 09:01
Shares of companies within the broader financials sector are trading lower, pos...
06-04 03:49
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Shift4业绩会实录,以下是公司财务业绩回顾摘要: ## 1. 财务业绩 **全年业绩表现:** - 总营收(Gross Revenue):41.8亿美元,超出此前指导区间高端,同比增长34% - 扣除网络费用后营收(GRLNF):19.8亿美元,同比增长46% - 调整后EBITDA:9.7亿美元,同比增长43%,调整后EBITDA利润率达49% - 调整后自由现金流:5亿美元,超出指导转换率区间150个基点 - 端到端支付量:2,090亿美元,接近管理层指导区间高端 - 混合利差:全年61个基点,超出"高于60个基点"的指导 **第四季度业
06-02 12:18
今日重点评级关注:Tigress Financial:维持英伟达"强力买入"评级,目标价从360美元升至425美元;康托·菲茨杰拉德:维持DeFi Development"超配"评级,目标价从6美元升至7美元
05-28 19:00
Truist Securities analyst Matthew Coad maintains Shift4 Payments (NYSE:FOUR) with a Hold and lowers the price target from $50 to $46.
05-28 01:52
Shift4 (NYSE:FOUR), the global commerce technology provider powering the experience economy, and Lydian, the global crypto and stablecoin payment platform, today announced a partnership to expand upon Shift4's Pay with
05-14 21:02
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46